Thông tin thuốc của Bilastine

Thông tin này không áp dụng cho tất cả các quốc gia. Vui lòng tham khảo thông tin kê toa lưu hành tại Việt Nam.

Thông tin thuốc gốc

Chỉ định và Liều dùng

Oral
Allergic rhinitis

Adult: For symptomatic relief of allergic rhino-conjunctivitis (seasonal allergic rhinitis and perennial allergic rhinitis): As conventional tab: 20 mg once daily. Limit treatment to the period of exposure to allergens. Seasonal allergic rhinitis: Discontinue treatment after the symptoms have resolved, reinitiate treatment if symptoms reappear. Perennial allergic rhinitis: Treatment may be continued during allergen exposure periods.
Child: For symptomatic relief of allergic rhino-conjunctivitis (seasonal allergic rhinitis and perennial allergic rhinitis): 6-11 years weighing at least 20 kg: As orodispersible tab and oral solution: 10 mg once daily. ≥12 years Same as adult dose.

Oral
Urticaria

Adult: As conventional tab: 20 mg once daily. Treatment duration may vary depending on the type, duration, and course of the complaints.
Child: 6-11 years weighing at least 20 kg: As orodispersible tab and oral solution: 10 mg once daily. ≥12 years Same as adult dose.

Cách dùng

Should be taken on an empty stomach. Take 1 hr before or 2 hr after intake of food or fruit juice.

Thận trọng

Concomitant use with P-glycoprotein inhibitors in patients with moderate to severe renal impairment. Children. Pregnancy and lactation.

Tác dụng không mong muốn

Cardiac disorders: Right bundle branch block, sinus arrhythmia.
Ear and labyrinth disorders: Vertigo, tinnitus.
Gastrointestinal disorders: Nausea, diarrhoea, dry mouth, thirst, dyspepsia, gastritis, upper abdominal pain, abdominal pain.
General disorders and administration site conditions: Fatigue, asthenia, pyrexia.
Infections and infestations: Oral herpes.
Investigations: Increased gamma glutamyltransferase, alanine aminotransferase, aspartate aminotransferase, blood creatinine, triglycerides, and weight.
Metabolism and nutrition disorders: Increased appetite.
Nervous system disorders: Somnolence, headache, dizziness.
Psychiatric disorders: Anxiety, insomnia.
Respiratory, thoracic and mediastinal disorders: Nasal discomfort, nasal dryness, dyspnoea.
Skin and subcutaneous tissue disorders: Pruritus.

Quá liều

Symptoms: Nausea, headache, dizziness. Management: Symptomatic and supportive treatment.

Tương tác

May increase the plasma concentrations and increase the risk of adverse reactions with P-glycoprotein inhibitors (e.g. ketoconazole, erythromycin, ciclosporin, ritonavir, and diltiazem).

Tương tác với thức ăn

Decreased bioavailability with grapefruit juice and possibly with other fruit juices. May increase the CNS depressant effect of alcohol.

Tác dụng

Description:
Mechanism of Action: Bilastine is a non-sedating, long-acting antihistamine. It has no affinity for muscarinic receptors but has selective peripheral H₁ receptor antagonist affinity.
Onset: 1 hour.
Duration: 26 hours.
Pharmacokinetics:
Absorption: Rapidly absorbed from the gastrointestinal tract. Bioavailability: Approx 61%; decreased with food. Time to peak plasma concentration: 1.13 hours.
Distribution: Plasma protein binding: 84-90%.
Metabolism: Minimally metabolised.
Excretion: Via faeces (66.5% as unchanged drug); urine (28.3% as unchanged drug). Elimination half-life: Approx 14.5 hours.

Đặc tính

Chemical Structure Image — **Bilastine**

Bảo quản

Store between 15-30°C.

Phân loại MIMS

Thuốc kháng histamin & kháng dị ứng

Phân loại ATC

R06AX29 - bilastine ; Belongs to the class of other antihistamines for systemic use.

Tài liệu tham khảo

Anon. Bilastine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 04/03/2022.

Bilaxten 10 mg Orodispersible Tablets (A. Menarini Manufacturing Logistics and Services S.r.l,). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 04/03/2022.

Bilaxten 2.5 mg/mL Oral Solution (Berlin-Chemia AG). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 04/03/2022.

Bilaxten 20 mg Tablets (A. Menarini Manufacturing Logistics and Services S.r.l,). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 04/03/2022.

Buckingham R (ed). Bilastine. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 04/03/2022.

Ilaxten 10 mg Orodispersible Tablets (Menarini International Operations Luxembourg S.A.). MHRA. https://products.mhra.gov.uk. Accessed 04/03/2022.

Ilaxten 2.5 mg/mL Oral Solution (Menarini International Operations Luxembourg S.A.). MHRA. https://products.mhra.gov.uk. Accessed 04/03/2022.

Ilaxten 20 mg Tablets (Menarini International Operations Luxembourg S.A.). MHRA. https://products.mhra.gov.uk. Accessed 04/03/2022.

Joint Formulary Committee. Bilastine. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 04/03/2022.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Bilastine từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com